Patent · US Active

Biomarkers predictive of cytokine release syndrome

US11747346B2 · kind B2 · utility

1Cited by

43References

25Claims

0Family size

Assignees

Novartis AG · CH
The Trustees of the University of Pennsylvania · US

Inventors

Alfred Garfall · Wallingford, US
Alex Ganetsky · Philadelphia, US
Saar Gill · Philadelphia, US
Simon Lacey · Durham, US
Jan J. Melenhorst · Cherry Hill, US
David Teachey · Rutledge, US
Eric Lancaster · Longmont, US
Adam David Cohen · Philadelphia, US
Pamela Shaw · Seattle, US

Key dates

Filing date	Sep 2, 2016
Grant date	Sep 5, 2023
Priority date	—
Expiry date	Dec 12, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/7095
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to the identification and use of biomarkers (e.g., analytes, analyte profiles, or markers (e.g., gene expression and/or protein expression profiles)) with clinical relevance to cytokine release syndrome (CRS).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.